688068 热景生物
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-1.2260.81730.580121.89716.150
总资产报酬率 ROA (%)-1.1640.73325.04696.13313.766
投入资产回报率 ROIC (%)-1.2140.79928.652111.84913.971

边际利润分析
销售毛利率 (%)52.43656.95353.71159.53863.012
营业利润率 (%)-9.9163.18030.67248.13424.916
息税前利润/营业总收入 (%)-14.998-5.40929.29048.15124.514
净利润/营业总收入 (%)-11.0532.78126.01241.01921.673

收益指标分析
经营活动净收益/利润总额(%)155.081-355.323117.095102.71690.402
价值变动净收益/利润总额(%)-27.206-165.2281.0150.9646.378
营业外收支净额/利润总额(%)-1.165-27.437-1.454-0.101-0.413

偿债能力分析
流动比率 (X)9.8494.4573.5173.4294.079
速动比率 (X)8.9493.7313.2153.0773.202
资产负债率 (%)4.4225.76813.99221.15417.254
带息债务/全部投入资本 (%)0.0910.7572.1538.587--
股东权益/带息债务 (%)108,755.29013,046.3654,497.7711,050.88923,935.860
股东权益/负债合计 (%)2,161.0561,634.569611.307368.803476.954
利息保障倍数 (X)2.8860.684-31.106738.811-81.991

营运能力分析
应收账款周转天数 (天)35.72541.1016.7272.1390.000
存货周转天数 (天)185.585224.87945.14231.8930.000